JBNI has received an FDA Investigational New Drug Number for our novel natural drug for chronic and debilitating Asthma. This is the first in a line of comprehensive natural, efficacious therapies for chronic medical conditions. Results of our research conducted in conjunction with CTRC Institute for Drug Development, San Antonio, TX, were presented in an abstract entitled "Efficacy, short-term safety, and serum biomarkers in a clinical trial of IND#70190" at the San Antonio Cancer Institute by Dr. Elzbieta Izbicka, chief investigator.
http://jbni.us/images/news1.jpg
Wednesday, June 25, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment